• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision on whether to keep or stop taking Adhd Medication Pregnancy (Mehmetnuriarslan.Com) medication during pregnancy and breast-feeding. There aren't many studies on how long-term exposure may affect the pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of taking them against the potential risks to the fetus. Physicians do not have the information needed to make unequivocal recommendations but they can provide information about benefits and risks that can assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers conducted a massive population-based case control study to compare the incidence of structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Clinical geneticists and pediatric cardiologists examined the cases to ensure accurate case classification and to minimize the chance of bias.

However, the study had its limitations. Researchers were unable to, in the first place to distinguish the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine whether the small associations observed among the groups exposed were due to medication use or confounded by co-morbidities. Additionally, the researchers did not look at long-term offspring outcomes.

The study revealed that infants whose mother took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated risk of having a caesarean birth or having a baby with low Apgar score (less than 7). These risks did not appear to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies could be offset by the greater benefits to both baby and mother of continued treatment for the woman’s disorder. Physicians should discuss this with their patients and, when they are able, assist them in developing strategies for improving their coping skills which can reduce the negative impact of her condition on her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to maintain treatment or stop as more women are diagnosed with ADHD. These decisions are usually made without clear and reliable evidence. Instead, doctors have to weigh their own knowledge and experience, as well as the experiences of other doctors and the research on the subject.

The issue of possible risks to infants is extremely difficult. The research on this issue is based on observation rather than controlled studies and a lot of the results are contradictory. The majority of studies restrict their analysis to live births, which can underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study discussed in this journal club addresses these limitations by examining data on both live and deceased births.

Conclusion A few studies have shown a positive correlation between uk adhd medication medications and certain birth defects, other studies have not established a link. most common adhd medication uk studies have shown a neutral, or even slightly negative, impact. Therefore, a careful risk/benefit analysis must be done in each instance.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In fact, in a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness, and family conflict for these patients. Additionally, the loss of medication can affect the ability to complete jobs and drive safely that are crucial aspects of a normal life for many people suffering from ADHD.

She suggests women who are uncertain about whether or not to stop medication in light of their pregnancy should consider educating family members, friends, and coworkers on the condition, its effects on daily functioning, and on the benefits of keeping the current treatment regimen. Educating them can also make the woman feel more comfortable when she is struggling with her decision. Some medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns over the impact that these drugs might have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers utilized two massive data sets to study more than 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers of the study did not discover any link between early use of medication and other congenital anomalies like facial deformities or club feet. The results are in line with previous studies that showed an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of the time of pregnancy. The risk increased in the latter part of pregnancy, when a lot of women decided to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely need a caesarean or have a low Apgar after birth and have a baby that needed breathing assistance at birth. The authors of the study could not remove bias in selection since they limited the study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope their research will provide doctors with information when they meet pregnant women. The researchers recommend that while discussing the risks and benefits are crucial, the decision regarding whether or not to stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also caution that, while stopping the medication is an option, it isn't a recommended practice because of the high rate of depression and other mental health issues for women who are expecting or recently post-partum. Further, the research suggests that women who choose to stop taking their medications are more likely to experience a difficult time adjusting to life without them after the baby's arrival.

Nursing

The responsibilities of a new mother can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments as well as getting ready for the arrival of their child and adjusting to new household routines can experience severe challenges. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs are absorbed through breast milk in very small amounts, therefore the risk to nursing infant is very low. The amount of exposure to medications can vary depending upon the dosage the medication is administered, its frequency and the time of day. In addition, different medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact on a newborn's health is not fully understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the mother, who must weigh the advantages of taking her medication as well as the risks to the embryo. Until more information becomes available, doctors can inquire about pregnant patients if they have a history of ADHD or if they are planning to take medication during the perinatal period.

A increasing number of studies have shown that the majority of women are able to safely continue taking their ADHD medication during pregnancy and breastfeeding. This has led to an increasing number of patients opt to do this, and after consulting with their doctor, they have found that the benefits of keeping their current medication far exceed any risk.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD understand the symptoms and the underlying disorder. They should also be educated about treatment options and strengthen strategies for coping. This should be a multidisciplinary process including obstetricians, GPs and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, and monitoring for indicators of deterioration, and, if needed, adjustments to the medication regimen.